Clinical Trial Update: A Post Marketing Surveillance on Piqray in Korea

View source ↗

Summary

This post-marketing surveillance study in Korea evaluates the safety and real-world use of Piqray (alpelisib) for breast cancer, with participant recruitment cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Piqray (alpelisib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Status: RECRUITING